European Journal of Clinical Investigation

Papers
(The H4-Index of European Journal of Clinical Investigation is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
148
Combination therapy with an SGLT‐2 inhibitor and finerenone in DKD: Are we there yet?100
Progress and challenges in the symbiosis of AI with science and medicine88
Adipocyte maturation impacts daunorubicin disposition and metabolism81
Clinical outcomes and phylogenetic analysis in reflection with three predominant clades of SARS‐CoV‐2 variants79
Correction to ‘Association Between Exposure to Air Pollution and Blood Lipids in the General Population of Spain’73
Effects of glucagon‐like PEPTIDE‐1 receptor agonists on incidence of hepatocellular carcinoma and liver decompensation in patients with diabetes: A systematic review and META‐analysis49
Issue Information45
Clinical predictors of late SARS‐CoV‐2 positivity in Italian internal medicine wards41
Clinical implications of vascular dysfunction in acute and convalescent COVID‐19: A systematic review40
Role of PERK‐mediated pathway in the effect of mild hypothermia after cerebral ischaemia/reperfusion38
Glucagon and glucagon‐like peptide‐1 dual agonist therapy: A possible future towards fatty kidney disease37
Human blood metabolites and risk of severe COVID‐19: A Mendelian randomization study37
Angiotensin‐converting enzyme 2 and transmembrane protease serine 2 in female and male patients with end‐stage kidney disease36
Impact of sirolimus on long‐term adverse cardiovascular outcomes in kidney transplant recipients: A nationwide cohort study36
Clinical use of controlled oxygenated rewarming of kidney grafts prior to transplantation by ex vivo machine perfusion. A pilot study33
Hydrogen sulphide: Diabetic cardiomyopathy as the paradigm of its pleiotropic function33
New insights into Covid‐19 disease. Apo‐A1 antibodies are generated after mRNA Covid‐19 vaccination and after Covid‐19 infection33
Does hospitalisation improve oral anticoagulant optimisation in patients with atrial fibrillation?31
Effects of pharmacological inhibition of hyaluronic acid synthesis on experimental endometriosis31
Seasonal vitamin D levels and lupus low disease activity state in systemic lupus erythematosus29
Issue Information28
rFVIII‐Fc in severe haemophilia A: The incentive switch in case of high risk of joint bleedings28
Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease27
The role of vascular smooth muscle cells in the development of aortic aneurysms and dissections27
The use of the Crohn's disease exclusion diet (CDED) in adults with Crohn's disease: A randomized controlled trial27
ACKR3 agonism induces heterodimerization with chemokine receptor CXCR4 and attenuates platelet function26
Social determinants of health and cardiovascular outcomes in patients with heart failure26
0.16952896118164